Global Targeted Drugs for Parkinson's Disease Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Targeted Drugs for Parkinson's Disease market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Targeted Drugs for Parkinson's Disease Industry Forecast” looks at past sales and reviews total world Targeted Drugs for Parkinson's Disease sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted Drugs for Parkinson's Disease sales for 2023 through 2029. With Targeted Drugs for Parkinson's Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Drugs for Parkinson's Disease industry.
This Insight Report provides a comprehensive analysis of the global Targeted Drugs for Parkinson's Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Drugs for Parkinson's Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drugs for Parkinson's Disease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drugs for Parkinson's Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drugs for Parkinson's Disease.
United States market for Targeted Drugs for Parkinson's Disease is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Targeted Drugs for Parkinson's Disease is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Targeted Drugs for Parkinson's Disease is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Targeted Drugs for Parkinson's Disease players cover Acadia Pharmaceuticals Inc., Kyowa Kirin, Supernus Pharmaceuticals, UCB, Sumitomo Pharma Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drugs for Parkinson's Disease market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Targeted Drugs for Parkinson's Disease market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Targeted Drugs for Parkinson's Disease Industry Forecast” looks at past sales and reviews total world Targeted Drugs for Parkinson's Disease sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted Drugs for Parkinson's Disease sales for 2023 through 2029. With Targeted Drugs for Parkinson's Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Drugs for Parkinson's Disease industry.
This Insight Report provides a comprehensive analysis of the global Targeted Drugs for Parkinson's Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Drugs for Parkinson's Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drugs for Parkinson's Disease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drugs for Parkinson's Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drugs for Parkinson's Disease.
United States market for Targeted Drugs for Parkinson's Disease is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Targeted Drugs for Parkinson's Disease is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Targeted Drugs for Parkinson's Disease is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Targeted Drugs for Parkinson's Disease players cover Acadia Pharmaceuticals Inc., Kyowa Kirin, Supernus Pharmaceuticals, UCB, Sumitomo Pharma Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drugs for Parkinson's Disease market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Capsule
- Patch
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Capsule
- Patch
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Acadia Pharmaceuticals Inc.
- Kyowa Kirin
- Supernus Pharmaceuticals
- UCB
- Sumitomo Pharma Co., Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Drugs for Parkinson's Disease Market Size 2019-2030
2.1.2 Targeted Drugs for Parkinson's Disease Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Targeted Drugs for Parkinson's Disease by Country/Region, 2019, 2023 & 2030
2.2 Targeted Drugs for Parkinson's Disease Segment by Type
2.2.1 Capsule
2.2.2 Patch
2.2.3 Other
2.3 Targeted Drugs for Parkinson's Disease Market Size by Type
2.3.1 Targeted Drugs for Parkinson's Disease Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Targeted Drugs for Parkinson's Disease Market Size Market Share by Type (2019-2024)
2.4 Targeted Drugs for Parkinson's Disease Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Targeted Drugs for Parkinson's Disease Market Size by Application
2.5.1 Targeted Drugs for Parkinson's Disease Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Targeted Drugs for Parkinson's Disease Market Size Market Share by Application (2019-2024)
3 TARGETED DRUGS FOR PARKINSON'S DISEASE MARKET SIZE BY PLAYER
3.1 Targeted Drugs for Parkinson's Disease Market Size Market Share by Player
3.1.1 Global Targeted Drugs for Parkinson's Disease Revenue by Player (2019-2024)
3.1.2 Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Player (2019-2024)
3.2 Global Targeted Drugs for Parkinson's Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED DRUGS FOR PARKINSON'S DISEASE BY REGION
4.1 Targeted Drugs for Parkinson's Disease Market Size by Region (2019-2024)
4.2 Global Targeted Drugs for Parkinson's Disease Annual Revenue by Country/Region (2019-2024)
4.3 Americas Targeted Drugs for Parkinson's Disease Market Size Growth (2019-2024)
4.4 APAC Targeted Drugs for Parkinson's Disease Market Size Growth (2019-2024)
4.5 Europe Targeted Drugs for Parkinson's Disease Market Size Growth (2019-2024)
4.6 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Targeted Drugs for Parkinson's Disease Market Size by Country (2019-2024)
5.2 Americas Targeted Drugs for Parkinson's Disease Market Size by Type (2019-2024)
5.3 Americas Targeted Drugs for Parkinson's Disease Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Drugs for Parkinson's Disease Market Size by Region (2019-2024)
6.2 APAC Targeted Drugs for Parkinson's Disease Market Size by Type (2019-2024)
6.3 APAC Targeted Drugs for Parkinson's Disease Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Drugs for Parkinson's Disease Market Size by Country (2019-2024)
7.2 Europe Targeted Drugs for Parkinson's Disease Market Size by Type (2019-2024)
7.3 Europe Targeted Drugs for Parkinson's Disease Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Drugs for Parkinson's Disease by Region (2019-2024)
8.2 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Type (2019-2024)
8.3 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED DRUGS FOR PARKINSON'S DISEASE MARKET FORECAST
10.1 Global Targeted Drugs for Parkinson's Disease Forecast by Region (2025-2030)
10.1.1 Global Targeted Drugs for Parkinson's Disease Forecast by Region (2025-2030)
10.1.2 Americas Targeted Drugs for Parkinson's Disease Forecast
10.1.3 APAC Targeted Drugs for Parkinson's Disease Forecast
10.1.4 Europe Targeted Drugs for Parkinson's Disease Forecast
10.1.5 Middle East & Africa Targeted Drugs for Parkinson's Disease Forecast
10.2 Americas Targeted Drugs for Parkinson's Disease Forecast by Country (2025-2030)
10.2.1 United States Market Targeted Drugs for Parkinson's Disease Forecast
10.2.2 Canada Market Targeted Drugs for Parkinson's Disease Forecast
10.2.3 Mexico Market Targeted Drugs for Parkinson's Disease Forecast
10.2.4 Brazil Market Targeted Drugs for Parkinson's Disease Forecast
10.3 APAC Targeted Drugs for Parkinson's Disease Forecast by Region (2025-2030)
10.3.1 China Targeted Drugs for Parkinson's Disease Market Forecast
10.3.2 Japan Market Targeted Drugs for Parkinson's Disease Forecast
10.3.3 Korea Market Targeted Drugs for Parkinson's Disease Forecast
10.3.4 Southeast Asia Market Targeted Drugs for Parkinson's Disease Forecast
10.3.5 India Market Targeted Drugs for Parkinson's Disease Forecast
10.3.6 Australia Market Targeted Drugs for Parkinson's Disease Forecast
10.4 Europe Targeted Drugs for Parkinson's Disease Forecast by Country (2025-2030)
10.4.1 Germany Market Targeted Drugs for Parkinson's Disease Forecast
10.4.2 France Market Targeted Drugs for Parkinson's Disease Forecast
10.4.3 UK Market Targeted Drugs for Parkinson's Disease Forecast
10.4.4 Italy Market Targeted Drugs for Parkinson's Disease Forecast
10.4.5 Russia Market Targeted Drugs for Parkinson's Disease Forecast
10.5 Middle East & Africa Targeted Drugs for Parkinson's Disease Forecast by Region (2025-2030)
10.5.1 Egypt Market Targeted Drugs for Parkinson's Disease Forecast
10.5.2 South Africa Market Targeted Drugs for Parkinson's Disease Forecast
10.5.3 Israel Market Targeted Drugs for Parkinson's Disease Forecast
10.5.4 Turkey Market Targeted Drugs for Parkinson's Disease Forecast
10.6 Global Targeted Drugs for Parkinson's Disease Forecast by Type (2025-2030)
10.7 Global Targeted Drugs for Parkinson's Disease Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Targeted Drugs for Parkinson's Disease Forecast
11 KEY PLAYERS ANALYSIS
11.1 Acadia Pharmaceuticals Inc.
11.1.1 Acadia Pharmaceuticals Inc. Company Information
11.1.2 Acadia Pharmaceuticals Inc. Targeted Drugs for Parkinson's Disease Product Offered
11.1.3 Acadia Pharmaceuticals Inc. Targeted Drugs for Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Acadia Pharmaceuticals Inc. Main Business Overview
11.1.5 Acadia Pharmaceuticals Inc. Latest Developments
11.2 Kyowa Kirin
11.2.1 Kyowa Kirin Company Information
11.2.2 Kyowa Kirin Targeted Drugs for Parkinson's Disease Product Offered
11.2.3 Kyowa Kirin Targeted Drugs for Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Kyowa Kirin Main Business Overview
11.2.5 Kyowa Kirin Latest Developments
11.3 Supernus Pharmaceuticals
11.3.1 Supernus Pharmaceuticals Company Information
11.3.2 Supernus Pharmaceuticals Targeted Drugs for Parkinson's Disease Product Offered
11.3.3 Supernus Pharmaceuticals Targeted Drugs for Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Supernus Pharmaceuticals Main Business Overview
11.3.5 Supernus Pharmaceuticals Latest Developments
11.4 UCB
11.4.1 UCB Company Information
11.4.2 UCB Targeted Drugs for Parkinson's Disease Product Offered
11.4.3 UCB Targeted Drugs for Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 UCB Main Business Overview
11.4.5 UCB Latest Developments
11.5 Sumitomo Pharma Co., Ltd.
11.5.1 Sumitomo Pharma Co., Ltd. Company Information
11.5.2 Sumitomo Pharma Co., Ltd. Targeted Drugs for Parkinson's Disease Product Offered
11.5.3 Sumitomo Pharma Co., Ltd. Targeted Drugs for Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sumitomo Pharma Co., Ltd. Main Business Overview
11.5.5 Sumitomo Pharma Co., Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
.
Table 1.Targeted Drugs for Parkinson's Disease Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2.Targeted Drugs for Parkinson's Disease Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Capsule
Table 4. Major Players of Patch
Table 5. Major Players of Other
Table 6.Targeted Drugs for Parkinson's Disease Market Size CAGR byType (2019 VS 2023 VS 2030) & ($ millions)
Table 7. GlobalTargeted Drugs for Parkinson's Disease Market Size byType (2019-2024) & ($ millions)
Table 8. GlobalTargeted Drugs for Parkinson's Disease Market Size Market Share byType (2019-2024)
Table 9.Targeted Drugs for Parkinson's Disease Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. GlobalTargeted Drugs for Parkinson's Disease Market Size by Application (2019-2024) & ($ millions)
Table 11. GlobalTargeted Drugs for Parkinson's Disease Market Size Market Share by Application (2019-2024)
Table 12. GlobalTargeted Drugs for Parkinson's Disease Revenue by Player (2019-2024) & ($ millions)
Table 13. GlobalTargeted Drugs for Parkinson's Disease Revenue Market Share by Player (2019-2024)
Table 14.Targeted Drugs for Parkinson's Disease Key Players Head office and Products Offered
Table 15.Targeted Drugs for Parkinson's Disease Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. GlobalTargeted Drugs for Parkinson's Disease Market Size by Region (2019-2024) & ($ millions)
Table 19. GlobalTargeted Drugs for Parkinson's Disease Market Size Market Share by Region (2019-2024)
Table 20. GlobalTargeted Drugs for Parkinson's Disease Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. GlobalTargeted Drugs for Parkinson's Disease Revenue Market Share by Country/Region (2019-2024)
Table 22. AmericasTargeted Drugs for Parkinson's Disease Market Size by Country (2019-2024) & ($ millions)
Table 23. AmericasTargeted Drugs for Parkinson's Disease Market Size Market Share by Country (2019-2024)
Table 24. AmericasTargeted Drugs for Parkinson's Disease Market Size byType (2019-2024) & ($ millions)
Table 25. AmericasTargeted Drugs for Parkinson's Disease Market Size Market Share byType (2019-2024)
Table 26. AmericasTargeted Drugs for Parkinson's Disease Market Size by Application (2019-2024) & ($ millions)
Table 27. AmericasTargeted Drugs for Parkinson's Disease Market Size Market Share by Application (2019-2024)
Table 28. APACTargeted Drugs for Parkinson's Disease Market Size by Region (2019-2024) & ($ millions)
Table 29. APACTargeted Drugs for Parkinson's Disease Market Size Market Share by Region (2019-2024)
Table 30. APACTargeted Drugs for Parkinson's Disease Market Size byType (2019-2024) & ($ millions)
Table 31. APACTargeted Drugs for Parkinson's Disease Market Size by Application (2019-2024) & ($ millions)
Table 32. EuropeTargeted Drugs for Parkinson's Disease Market Size by Country (2019-2024) & ($ millions)
Table 33. EuropeTargeted Drugs for Parkinson's Disease Market Size Market Share by Country (2019-2024)
Table 34. EuropeTargeted Drugs for Parkinson's Disease Market Size byType (2019-2024) & ($ millions)
Table 35. EuropeTargeted Drugs for Parkinson's Disease Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size byType (2019-2024) & ($ millions)
Table 38. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities ofTargeted Drugs for Parkinson's Disease
Table 40. Key Market Challenges & Risks ofTargeted Drugs for Parkinson's Disease
Table 41. Key IndustryTrends ofTargeted Drugs for Parkinson's Disease
Table 42. GlobalTargeted Drugs for Parkinson's Disease Market SizeForecast by Region (2025-2030) & ($ millions)
Table 43. GlobalTargeted Drugs for Parkinson's Disease Market Size Market ShareForecast by Region (2025-2030)
Table 44. GlobalTargeted Drugs for Parkinson's Disease Market SizeForecast byType (2025-2030) & ($ millions)
Table 45. GlobalTargeted Drugs for Parkinson's Disease Market SizeForecast by Application (2025-2030) & ($ millions)
Table 46. Acadia Pharmaceuticals Inc. Details, CompanyType,Targeted Drugs for Parkinson's Disease Area Served and Its Competitors
Table 47. Acadia Pharmaceuticals Inc.Targeted Drugs for Parkinson's Disease Product Offered
Table 48. Acadia Pharmaceuticals Inc.Targeted Drugs for Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Acadia Pharmaceuticals Inc. Main Business
Table 50. Acadia Pharmaceuticals Inc. Latest Developments
Table 51. Kyowa Kirin Details, CompanyType,Targeted Drugs for Parkinson's Disease Area Served and Its Competitors
Table 52. Kyowa KirinTargeted Drugs for Parkinson's Disease Product Offered
Table 53. Kyowa KirinTargeted Drugs for Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Kyowa Kirin Main Business
Table 55. Kyowa Kirin Latest Developments
Table 56. Supernus Pharmaceuticals Details, CompanyType,Targeted Drugs for Parkinson's Disease Area Served and Its Competitors
Table 57. Supernus PharmaceuticalsTargeted Drugs for Parkinson's Disease Product Offered
Table 58. Supernus PharmaceuticalsTargeted Drugs for Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Supernus Pharmaceuticals Main Business
Table 60. Supernus Pharmaceuticals Latest Developments
Table 61. UCB Details, CompanyType,Targeted Drugs for Parkinson's Disease Area Served and Its Competitors
Table 62. UCBTargeted Drugs for Parkinson's Disease Product Offered
Table 63. UCBTargeted Drugs for Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. UCB Main Business
Table 65. UCB Latest Developments
Table 66. Sumitomo Pharma Co., Ltd. Details, CompanyType,Targeted Drugs for Parkinson's Disease Area Served and Its Competitors
Table 67. Sumitomo Pharma Co., Ltd.Targeted Drugs for Parkinson's Disease Product Offered
Table 68. Sumitomo Pharma Co., Ltd.Targeted Drugs for Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Sumitomo Pharma Co., Ltd. Main Business
Table 70. Sumitomo Pharma Co., Ltd. Latest Developments
LIST OFFIGURES
.
Figure 1.Targeted Drugs for Parkinson's Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. GlobalTargeted Drugs for Parkinson's Disease Market Size Growth Rate 2019-2030 ($ millions)
Figure 6.Targeted Drugs for Parkinson's Disease Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7.Targeted Drugs for Parkinson's Disease Sales Market Share by Country/Region (2023)
Figure 8.Targeted Drugs for Parkinson's Disease Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. GlobalTargeted Drugs for Parkinson's Disease Market Size Market Share byType in 2023
Figure 10.Targeted Drugs for Parkinson's Disease in Hospital
Figure 11. GlobalTargeted Drugs for Parkinson's Disease Market: Hospital (2019-2024) & ($ millions)
Figure 12.Targeted Drugs for Parkinson's Disease in Clinic
Figure 13. GlobalTargeted Drugs for Parkinson's Disease Market: Clinic (2019-2024) & ($ millions)
Figure 14.Targeted Drugs for Parkinson's Disease in Other
Figure 15. GlobalTargeted Drugs for Parkinson's Disease Market: Other (2019-2024) & ($ millions)
Figure 16. GlobalTargeted Drugs for Parkinson's Disease Market Size Market Share by Application in 2023
Figure 17. GlobalTargeted Drugs for Parkinson's Disease Revenue Market Share by Player in 2023
Figure 18. GlobalTargeted Drugs for Parkinson's Disease Market Size Market Share by Region (2019-2024)
Figure 19. AmericasTargeted Drugs for Parkinson's Disease Market Size 2019-2024 ($ millions)
Figure 20. APACTargeted Drugs for Parkinson's Disease Market Size 2019-2024 ($ millions)
Figure 21. EuropeTargeted Drugs for Parkinson's Disease Market Size 2019-2024 ($ millions)
Figure 22. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size 2019-2024 ($ millions)
Figure 23. AmericasTargeted Drugs for Parkinson's Disease Value Market Share by Country in 2023
Figure 24. United StatesTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 25. CanadaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 26. MexicoTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 27. BrazilTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 28. APACTargeted Drugs for Parkinson's Disease Market Size Market Share by Region in 2023
Figure 29. APACTargeted Drugs for Parkinson's Disease Market Size Market Share byType (2019-2024)
Figure 30. APACTargeted Drugs for Parkinson's Disease Market Size Market Share by Application (2019-2024)
Figure 31. ChinaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 32. JapanTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 33. South KoreaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast AsiaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 35. IndiaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 36. AustraliaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 37. EuropeTargeted Drugs for Parkinson's Disease Market Size Market Share by Country in 2023
Figure 38. EuropeTargeted Drugs for Parkinson's Disease Market Size Market Share byType (2019-2024)
Figure 39. EuropeTargeted Drugs for Parkinson's Disease Market Size Market Share by Application (2019-2024)
Figure 40. GermanyTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 41.FranceTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 42. UKTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 43. ItalyTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 44. RussiaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size Market Share byType (2019-2024)
Figure 47. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size Market Share by Application (2019-2024)
Figure 48. EgyptTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 49. South AfricaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 50. IsraelTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 51.TurkeyTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC CountriesTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 53. AmericasTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 54. APACTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 55. EuropeTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 56. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 57. United StatesTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 58. CanadaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 59. MexicoTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 60. BrazilTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 61. ChinaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 62. JapanTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 63. KoreaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 64. Southeast AsiaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 65. IndiaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 66. AustraliaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 67. GermanyTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 68.FranceTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 69. UKTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 70. ItalyTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 71. RussiaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 72. EgyptTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 73. South AfricaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 74. IsraelTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 75.TurkeyTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 76. GCC CountriesTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 77. GlobalTargeted Drugs for Parkinson's Disease Market Size Market ShareForecast byType (2025-2030)
Figure 78. GlobalTargeted Drugs for Parkinson's Disease Market Size Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Drugs for Parkinson's Disease Market Size 2019-2030
2.1.2 Targeted Drugs for Parkinson's Disease Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Targeted Drugs for Parkinson's Disease by Country/Region, 2019, 2023 & 2030
2.2 Targeted Drugs for Parkinson's Disease Segment by Type
2.2.1 Capsule
2.2.2 Patch
2.2.3 Other
2.3 Targeted Drugs for Parkinson's Disease Market Size by Type
2.3.1 Targeted Drugs for Parkinson's Disease Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Targeted Drugs for Parkinson's Disease Market Size Market Share by Type (2019-2024)
2.4 Targeted Drugs for Parkinson's Disease Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Targeted Drugs for Parkinson's Disease Market Size by Application
2.5.1 Targeted Drugs for Parkinson's Disease Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Targeted Drugs for Parkinson's Disease Market Size Market Share by Application (2019-2024)
3 TARGETED DRUGS FOR PARKINSON'S DISEASE MARKET SIZE BY PLAYER
3.1 Targeted Drugs for Parkinson's Disease Market Size Market Share by Player
3.1.1 Global Targeted Drugs for Parkinson's Disease Revenue by Player (2019-2024)
3.1.2 Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Player (2019-2024)
3.2 Global Targeted Drugs for Parkinson's Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED DRUGS FOR PARKINSON'S DISEASE BY REGION
4.1 Targeted Drugs for Parkinson's Disease Market Size by Region (2019-2024)
4.2 Global Targeted Drugs for Parkinson's Disease Annual Revenue by Country/Region (2019-2024)
4.3 Americas Targeted Drugs for Parkinson's Disease Market Size Growth (2019-2024)
4.4 APAC Targeted Drugs for Parkinson's Disease Market Size Growth (2019-2024)
4.5 Europe Targeted Drugs for Parkinson's Disease Market Size Growth (2019-2024)
4.6 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Targeted Drugs for Parkinson's Disease Market Size by Country (2019-2024)
5.2 Americas Targeted Drugs for Parkinson's Disease Market Size by Type (2019-2024)
5.3 Americas Targeted Drugs for Parkinson's Disease Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Drugs for Parkinson's Disease Market Size by Region (2019-2024)
6.2 APAC Targeted Drugs for Parkinson's Disease Market Size by Type (2019-2024)
6.3 APAC Targeted Drugs for Parkinson's Disease Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Drugs for Parkinson's Disease Market Size by Country (2019-2024)
7.2 Europe Targeted Drugs for Parkinson's Disease Market Size by Type (2019-2024)
7.3 Europe Targeted Drugs for Parkinson's Disease Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Drugs for Parkinson's Disease by Region (2019-2024)
8.2 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Type (2019-2024)
8.3 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED DRUGS FOR PARKINSON'S DISEASE MARKET FORECAST
10.1 Global Targeted Drugs for Parkinson's Disease Forecast by Region (2025-2030)
10.1.1 Global Targeted Drugs for Parkinson's Disease Forecast by Region (2025-2030)
10.1.2 Americas Targeted Drugs for Parkinson's Disease Forecast
10.1.3 APAC Targeted Drugs for Parkinson's Disease Forecast
10.1.4 Europe Targeted Drugs for Parkinson's Disease Forecast
10.1.5 Middle East & Africa Targeted Drugs for Parkinson's Disease Forecast
10.2 Americas Targeted Drugs for Parkinson's Disease Forecast by Country (2025-2030)
10.2.1 United States Market Targeted Drugs for Parkinson's Disease Forecast
10.2.2 Canada Market Targeted Drugs for Parkinson's Disease Forecast
10.2.3 Mexico Market Targeted Drugs for Parkinson's Disease Forecast
10.2.4 Brazil Market Targeted Drugs for Parkinson's Disease Forecast
10.3 APAC Targeted Drugs for Parkinson's Disease Forecast by Region (2025-2030)
10.3.1 China Targeted Drugs for Parkinson's Disease Market Forecast
10.3.2 Japan Market Targeted Drugs for Parkinson's Disease Forecast
10.3.3 Korea Market Targeted Drugs for Parkinson's Disease Forecast
10.3.4 Southeast Asia Market Targeted Drugs for Parkinson's Disease Forecast
10.3.5 India Market Targeted Drugs for Parkinson's Disease Forecast
10.3.6 Australia Market Targeted Drugs for Parkinson's Disease Forecast
10.4 Europe Targeted Drugs for Parkinson's Disease Forecast by Country (2025-2030)
10.4.1 Germany Market Targeted Drugs for Parkinson's Disease Forecast
10.4.2 France Market Targeted Drugs for Parkinson's Disease Forecast
10.4.3 UK Market Targeted Drugs for Parkinson's Disease Forecast
10.4.4 Italy Market Targeted Drugs for Parkinson's Disease Forecast
10.4.5 Russia Market Targeted Drugs for Parkinson's Disease Forecast
10.5 Middle East & Africa Targeted Drugs for Parkinson's Disease Forecast by Region (2025-2030)
10.5.1 Egypt Market Targeted Drugs for Parkinson's Disease Forecast
10.5.2 South Africa Market Targeted Drugs for Parkinson's Disease Forecast
10.5.3 Israel Market Targeted Drugs for Parkinson's Disease Forecast
10.5.4 Turkey Market Targeted Drugs for Parkinson's Disease Forecast
10.6 Global Targeted Drugs for Parkinson's Disease Forecast by Type (2025-2030)
10.7 Global Targeted Drugs for Parkinson's Disease Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Targeted Drugs for Parkinson's Disease Forecast
11 KEY PLAYERS ANALYSIS
11.1 Acadia Pharmaceuticals Inc.
11.1.1 Acadia Pharmaceuticals Inc. Company Information
11.1.2 Acadia Pharmaceuticals Inc. Targeted Drugs for Parkinson's Disease Product Offered
11.1.3 Acadia Pharmaceuticals Inc. Targeted Drugs for Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Acadia Pharmaceuticals Inc. Main Business Overview
11.1.5 Acadia Pharmaceuticals Inc. Latest Developments
11.2 Kyowa Kirin
11.2.1 Kyowa Kirin Company Information
11.2.2 Kyowa Kirin Targeted Drugs for Parkinson's Disease Product Offered
11.2.3 Kyowa Kirin Targeted Drugs for Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Kyowa Kirin Main Business Overview
11.2.5 Kyowa Kirin Latest Developments
11.3 Supernus Pharmaceuticals
11.3.1 Supernus Pharmaceuticals Company Information
11.3.2 Supernus Pharmaceuticals Targeted Drugs for Parkinson's Disease Product Offered
11.3.3 Supernus Pharmaceuticals Targeted Drugs for Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Supernus Pharmaceuticals Main Business Overview
11.3.5 Supernus Pharmaceuticals Latest Developments
11.4 UCB
11.4.1 UCB Company Information
11.4.2 UCB Targeted Drugs for Parkinson's Disease Product Offered
11.4.3 UCB Targeted Drugs for Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 UCB Main Business Overview
11.4.5 UCB Latest Developments
11.5 Sumitomo Pharma Co., Ltd.
11.5.1 Sumitomo Pharma Co., Ltd. Company Information
11.5.2 Sumitomo Pharma Co., Ltd. Targeted Drugs for Parkinson's Disease Product Offered
11.5.3 Sumitomo Pharma Co., Ltd. Targeted Drugs for Parkinson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sumitomo Pharma Co., Ltd. Main Business Overview
11.5.5 Sumitomo Pharma Co., Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
.
Table 1.Targeted Drugs for Parkinson's Disease Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2.Targeted Drugs for Parkinson's Disease Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Capsule
Table 4. Major Players of Patch
Table 5. Major Players of Other
Table 6.Targeted Drugs for Parkinson's Disease Market Size CAGR byType (2019 VS 2023 VS 2030) & ($ millions)
Table 7. GlobalTargeted Drugs for Parkinson's Disease Market Size byType (2019-2024) & ($ millions)
Table 8. GlobalTargeted Drugs for Parkinson's Disease Market Size Market Share byType (2019-2024)
Table 9.Targeted Drugs for Parkinson's Disease Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. GlobalTargeted Drugs for Parkinson's Disease Market Size by Application (2019-2024) & ($ millions)
Table 11. GlobalTargeted Drugs for Parkinson's Disease Market Size Market Share by Application (2019-2024)
Table 12. GlobalTargeted Drugs for Parkinson's Disease Revenue by Player (2019-2024) & ($ millions)
Table 13. GlobalTargeted Drugs for Parkinson's Disease Revenue Market Share by Player (2019-2024)
Table 14.Targeted Drugs for Parkinson's Disease Key Players Head office and Products Offered
Table 15.Targeted Drugs for Parkinson's Disease Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. GlobalTargeted Drugs for Parkinson's Disease Market Size by Region (2019-2024) & ($ millions)
Table 19. GlobalTargeted Drugs for Parkinson's Disease Market Size Market Share by Region (2019-2024)
Table 20. GlobalTargeted Drugs for Parkinson's Disease Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. GlobalTargeted Drugs for Parkinson's Disease Revenue Market Share by Country/Region (2019-2024)
Table 22. AmericasTargeted Drugs for Parkinson's Disease Market Size by Country (2019-2024) & ($ millions)
Table 23. AmericasTargeted Drugs for Parkinson's Disease Market Size Market Share by Country (2019-2024)
Table 24. AmericasTargeted Drugs for Parkinson's Disease Market Size byType (2019-2024) & ($ millions)
Table 25. AmericasTargeted Drugs for Parkinson's Disease Market Size Market Share byType (2019-2024)
Table 26. AmericasTargeted Drugs for Parkinson's Disease Market Size by Application (2019-2024) & ($ millions)
Table 27. AmericasTargeted Drugs for Parkinson's Disease Market Size Market Share by Application (2019-2024)
Table 28. APACTargeted Drugs for Parkinson's Disease Market Size by Region (2019-2024) & ($ millions)
Table 29. APACTargeted Drugs for Parkinson's Disease Market Size Market Share by Region (2019-2024)
Table 30. APACTargeted Drugs for Parkinson's Disease Market Size byType (2019-2024) & ($ millions)
Table 31. APACTargeted Drugs for Parkinson's Disease Market Size by Application (2019-2024) & ($ millions)
Table 32. EuropeTargeted Drugs for Parkinson's Disease Market Size by Country (2019-2024) & ($ millions)
Table 33. EuropeTargeted Drugs for Parkinson's Disease Market Size Market Share by Country (2019-2024)
Table 34. EuropeTargeted Drugs for Parkinson's Disease Market Size byType (2019-2024) & ($ millions)
Table 35. EuropeTargeted Drugs for Parkinson's Disease Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size byType (2019-2024) & ($ millions)
Table 38. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities ofTargeted Drugs for Parkinson's Disease
Table 40. Key Market Challenges & Risks ofTargeted Drugs for Parkinson's Disease
Table 41. Key IndustryTrends ofTargeted Drugs for Parkinson's Disease
Table 42. GlobalTargeted Drugs for Parkinson's Disease Market SizeForecast by Region (2025-2030) & ($ millions)
Table 43. GlobalTargeted Drugs for Parkinson's Disease Market Size Market ShareForecast by Region (2025-2030)
Table 44. GlobalTargeted Drugs for Parkinson's Disease Market SizeForecast byType (2025-2030) & ($ millions)
Table 45. GlobalTargeted Drugs for Parkinson's Disease Market SizeForecast by Application (2025-2030) & ($ millions)
Table 46. Acadia Pharmaceuticals Inc. Details, CompanyType,Targeted Drugs for Parkinson's Disease Area Served and Its Competitors
Table 47. Acadia Pharmaceuticals Inc.Targeted Drugs for Parkinson's Disease Product Offered
Table 48. Acadia Pharmaceuticals Inc.Targeted Drugs for Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Acadia Pharmaceuticals Inc. Main Business
Table 50. Acadia Pharmaceuticals Inc. Latest Developments
Table 51. Kyowa Kirin Details, CompanyType,Targeted Drugs for Parkinson's Disease Area Served and Its Competitors
Table 52. Kyowa KirinTargeted Drugs for Parkinson's Disease Product Offered
Table 53. Kyowa KirinTargeted Drugs for Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Kyowa Kirin Main Business
Table 55. Kyowa Kirin Latest Developments
Table 56. Supernus Pharmaceuticals Details, CompanyType,Targeted Drugs for Parkinson's Disease Area Served and Its Competitors
Table 57. Supernus PharmaceuticalsTargeted Drugs for Parkinson's Disease Product Offered
Table 58. Supernus PharmaceuticalsTargeted Drugs for Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Supernus Pharmaceuticals Main Business
Table 60. Supernus Pharmaceuticals Latest Developments
Table 61. UCB Details, CompanyType,Targeted Drugs for Parkinson's Disease Area Served and Its Competitors
Table 62. UCBTargeted Drugs for Parkinson's Disease Product Offered
Table 63. UCBTargeted Drugs for Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. UCB Main Business
Table 65. UCB Latest Developments
Table 66. Sumitomo Pharma Co., Ltd. Details, CompanyType,Targeted Drugs for Parkinson's Disease Area Served and Its Competitors
Table 67. Sumitomo Pharma Co., Ltd.Targeted Drugs for Parkinson's Disease Product Offered
Table 68. Sumitomo Pharma Co., Ltd.Targeted Drugs for Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Sumitomo Pharma Co., Ltd. Main Business
Table 70. Sumitomo Pharma Co., Ltd. Latest Developments
LIST OFFIGURES
.
Figure 1.Targeted Drugs for Parkinson's Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. GlobalTargeted Drugs for Parkinson's Disease Market Size Growth Rate 2019-2030 ($ millions)
Figure 6.Targeted Drugs for Parkinson's Disease Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7.Targeted Drugs for Parkinson's Disease Sales Market Share by Country/Region (2023)
Figure 8.Targeted Drugs for Parkinson's Disease Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. GlobalTargeted Drugs for Parkinson's Disease Market Size Market Share byType in 2023
Figure 10.Targeted Drugs for Parkinson's Disease in Hospital
Figure 11. GlobalTargeted Drugs for Parkinson's Disease Market: Hospital (2019-2024) & ($ millions)
Figure 12.Targeted Drugs for Parkinson's Disease in Clinic
Figure 13. GlobalTargeted Drugs for Parkinson's Disease Market: Clinic (2019-2024) & ($ millions)
Figure 14.Targeted Drugs for Parkinson's Disease in Other
Figure 15. GlobalTargeted Drugs for Parkinson's Disease Market: Other (2019-2024) & ($ millions)
Figure 16. GlobalTargeted Drugs for Parkinson's Disease Market Size Market Share by Application in 2023
Figure 17. GlobalTargeted Drugs for Parkinson's Disease Revenue Market Share by Player in 2023
Figure 18. GlobalTargeted Drugs for Parkinson's Disease Market Size Market Share by Region (2019-2024)
Figure 19. AmericasTargeted Drugs for Parkinson's Disease Market Size 2019-2024 ($ millions)
Figure 20. APACTargeted Drugs for Parkinson's Disease Market Size 2019-2024 ($ millions)
Figure 21. EuropeTargeted Drugs for Parkinson's Disease Market Size 2019-2024 ($ millions)
Figure 22. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size 2019-2024 ($ millions)
Figure 23. AmericasTargeted Drugs for Parkinson's Disease Value Market Share by Country in 2023
Figure 24. United StatesTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 25. CanadaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 26. MexicoTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 27. BrazilTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 28. APACTargeted Drugs for Parkinson's Disease Market Size Market Share by Region in 2023
Figure 29. APACTargeted Drugs for Parkinson's Disease Market Size Market Share byType (2019-2024)
Figure 30. APACTargeted Drugs for Parkinson's Disease Market Size Market Share by Application (2019-2024)
Figure 31. ChinaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 32. JapanTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 33. South KoreaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast AsiaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 35. IndiaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 36. AustraliaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 37. EuropeTargeted Drugs for Parkinson's Disease Market Size Market Share by Country in 2023
Figure 38. EuropeTargeted Drugs for Parkinson's Disease Market Size Market Share byType (2019-2024)
Figure 39. EuropeTargeted Drugs for Parkinson's Disease Market Size Market Share by Application (2019-2024)
Figure 40. GermanyTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 41.FranceTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 42. UKTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 43. ItalyTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 44. RussiaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size Market Share byType (2019-2024)
Figure 47. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size Market Share by Application (2019-2024)
Figure 48. EgyptTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 49. South AfricaTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 50. IsraelTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 51.TurkeyTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC CountriesTargeted Drugs for Parkinson's Disease Market Size Growth 2019-2024 ($ millions)
Figure 53. AmericasTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 54. APACTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 55. EuropeTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 56. Middle East & AfricaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 57. United StatesTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 58. CanadaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 59. MexicoTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 60. BrazilTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 61. ChinaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 62. JapanTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 63. KoreaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 64. Southeast AsiaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 65. IndiaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 66. AustraliaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 67. GermanyTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 68.FranceTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 69. UKTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 70. ItalyTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 71. RussiaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 72. EgyptTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 73. South AfricaTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 74. IsraelTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 75.TurkeyTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 76. GCC CountriesTargeted Drugs for Parkinson's Disease Market Size 2025-2030 ($ millions)
Figure 77. GlobalTargeted Drugs for Parkinson's Disease Market Size Market ShareForecast byType (2025-2030)
Figure 78. GlobalTargeted Drugs for Parkinson's Disease Market Size Market ShareForecast by Application (2025-2030)
